Browse by Divisions (Kiel)

Up a level
Export as [feed] RSS [feed] RSS 3.0
Group by: Document type | Year of publication | Author/Editor | No Grouping
Number of items at this level: 55.

Article in a Scientific Journal - peer-reviewed


Apweiler, R., Aslanidis, C., Deufel, T., Gerstner, A., Hansen, J., Hochstrasser, D., Kellner, R., Kubicek, M., Lottspeich, F., Maser, E., Mewes, H. W., Meyer, H. E., Mullner, S., Mutter, W., Neumaier, M., Nollau, P., Nothwang, H. G., Ponten, F., Radbruch, A., Reinert, K., Rothe, G., Stockinger, H., Tarnok, A., Taussig, M. J., Thiel, A., Thiery, J., Ueffing, M., Valet, G., Vandekerckhove, J., Wagener, C., Wagner, O. and Schmitz, G. (2009) Approaching Clinical Proteomics: Current State and Future Fields of Application in Cellular Proteomics Cytometry Part A, 75A (10). pp. 816-832.


Apweiler, R., Aslanidis, C., Deufel, T., Gerstner, A., Hansen, J., Hochstrasser, D., Kellner, R., Kubicek, M., Lottspeich, F., Maser, E., Mewes, H. W., Meyer, H. E., Müllner, S., Mutter, W., Neumaier, M., Nollau, P., Nothwang, H. G., Ponten, F., Radbruch, A., Reinert, K., Rothe, G., Stockinger, H., Tarnok, A., Taussig, M. J., Thiel, A., Thiery, J., Ueffing, M., Valet, G., Vandekerckhove, J., Verhuven, W., Wagener, C., Wagner, O. and Schmitz, G. (2009) Approaching clinical proteomics: current state and future fields of application in fluid proteomics Clinical Chemistry and Laboratory Medicine, 47 (6). pp. 724-744.


Balendiran, G. K., Martin, H. J., El-Hawari, Y. and Maser, E. (2009) Cancer biomarker AKR1B10 and carbonyl metabolism Chemico-Biological Interactions, 178 (1-3). pp. 134-137.


Blum, A., Favia, A. D. and Maser, E. (2009) 11 beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds Molecular and Cellular Endocrinology, 301 (1-2). pp. 132-136.


Ebert, B., Kisiela, M. and Maser, E. (2016) Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) - an in silico approach Drug Metabolism Reviews, 48 (2). pp. 183-217. DOI 10.3109/03602532.2016.1167902.


Ebert, B., Kisiela, M., Wsol, V. and Maser, E. (2011) Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29 Chemico-Biological Interactions, 191 (1-3). pp. 239-249. DOI 10.1016/j.cbi.2010.12.026.


El-Hawari, Y., Favia, A. D., Pilka, E. S., Kisiela, M., Oppermann, U., Martin, H. J. and Maser, E. (2009) Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis Chemico-Biological Interactions, 178 (1-3). pp. 234-241.


El-Hawari, Y., Pilka, E., Martin, H. J., Oppermann, U. and Maser, E. (2008) Characterization of the human carbonyl reductase 3 (CBR3) by site-directed mutagenesis Naunyn-Schmiedeberg's Archives of Pharmacology , 377 . p. 326.


Flynn, T. G., Kedishvili, N., Maser, E., O'Brien, P. J. and Plapp, B. V. (2011) Introduction Chemico-Biological Interactions, 191 (1-3). p. 1. DOI 10.1016/j.cbi.2011.03.002.


Flynn, T. G., Kedishvili, N., Maser, E., O'Brien, P. J. and Plapp, B. V. (2011) Special Issue: Enzymology and Molecular Biology of Carbonyl Metabolism Introduction Chemico-Biological Interactions, 191 (1-3). p. 1. DOI 10.1016/j.cbi.2011.03.002.

[img]

Gohler, A., Xiong, G. M., Paulsen, S., Trentmann, G. and Maser, E. (2008) Testosterone-inducible regulator is a kinase that drives steroid sensing and metabolism in Comamonas testosteroni Journal of Biological Chemistry, 283 (25). pp. 17380-17390. DOI 10.1074/jbc.M710166200.


Hintzpeter, J., Seliger, J. M., Hofman, J., Martin, H. J., Wsol, V. and Maser, E. (2016) Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance Toxicology and Applied Pharmacology, 293 . pp. 21-29. DOI 10.1016/j.taap.2016.01.003.

[img]

Kassner, N., Huse, K., Martin, H. J., Godtel-Armbrust, U., Metzger, A., Meineke, I., Brockmoller, J., Klein, K., Zanger, U. M., Maser, E. and Wojnowski, L. (2008) Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver Drug Metabolism and Disposition, 36 (10). pp. 2113-2120. DOI DOI:10.1124/dmd.108.022251.


Kisiela, M., El-Hawari, Y., Martin, H. J. and Maser, E. (2011) Bioinformatic and biochemical characterization of DCXR and DHRS2/4 from Caenorhabditis elegans Chemico-Biological Interactions, 191 (1-3). pp. 75-82. DOI 10.1016/j.cbi.2011.01.034.


Kramm, A., Kisiela, M., Schulz, R. and Maser, E. (2012) Short-chain dehydrogenases/reductases in cyanobacteria Febs Journal, 279 (6). pp. 1030-1043.


Liang, J. L., Nie, Y., Wang, M. X., Xiong, G. M., Wang, Y. P., Maser, E. and Wu, X. L. (2016) Regulation of alkane degradation pathway by a TetR family repressor via an autoregulation positive feedback mechanism in a Gram-positive Dietzia bacterium Molecular Microbiology, 99 (2). pp. 338-359. DOI 10.1111/mmi.13232.


Linden, A., Gulden, M., Martin, H. J., Maser, E. and Seibert, H. (2008) Peroxide-induced cell death and lipid peroxidation in C6 glioma cells Toxicology In Vitro, 22 (5). pp. 1371-1376.


Loeffler-Ragg, J., Mueller, D., Gamerith, G., Auer, T., Skvortsov, S., Sarg, B., Skvortsova, I., Schmitz, K. J., Martin, H. J., Krugmann, J., Alakus, H., Maser, E., Menzel, J., Hilbe, W., Lindner, H., Schmid, K. W. and Zwierzina, H. (2009) Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib Molecular Cancer Therapeutics, 8 (7). pp. 1995-2006.


Martin, H. J. and Maser, E. (2009) Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes Chemico-Biological Interactions, 178 (1-3). pp. 145-150.


Martin, H. J., Ziemba, M., Kisiela, M., Botella, J. A., Schneuwly, S. and Maser, E. (2011) The Drosophila carbonyl reductase sniffer is an efficient 4-oxonon-2-enal (4ONE) reductase Chem Biol Interact, 191 (1-3). pp. 48-54. DOI S0009-2797(10)00643-5 pii 10.1016/j.cbi.2010.12.006.


Novotna, R., Wsol, V., Xiong, G. and Maser, E. (2008) Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3 Toxicology Letters, 181 (1). pp. 1-6.


Radunz, L., Westphal, F., Maser, E. and Rochholz, G. (2011) THCVA-A - A new additional marker for illegal cannabis consumption Forensic Sci Int . DOI S0379-0738(11)00115-0 pii 10.1016/j.forsciint.2011.03.001.


Rohl, C., Armbrust, E., Herbst, E., Jess, A., Gulden, M., Maser, E. and Bosch-Saadatmandi, C. (2009) Microglia-mediated increase of heme oxygenase-1 (HO-1), superoxide dismutase-2 (Sod-2) and glutathione and the effect of microglia on peroxide-induced generation of radical species and lipid peroxidation in astrocytes in vitro Naunyn-Schmiedeberg's Archives of Pharmacology , 379 . p. 67.


Rohl, C., Armbrust, E., Kolbe, K., Lucius, R., Maser, E., Venz, S. and Gulden, M. (2008) Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in vitro Glia, 56 (10). pp. 1114-1126. DOI 10.1002/glia.20683.


Ruweler, M., Anker, A., Gulden, M., Maser, E. and Seibert, H. (2008) Inhibition of peroxide-induced radical generation by plant polyphenols Toxicology In Vitro, 22 (5). pp. 1377-1381.


Ruweler, M., Gulden, M., Maser, E., Murias, M. and Seibert, H. (2009) Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro Chemico-Biological Interactions, 182 (2-3). pp. 128-135.


Sang, Y. Y., Xiong, G. M. and Maser, E. (2011) Steroid degradation and two steroid-inducible enzymes in the marine bacterium H5 Chemico-Biological Interactions, 191 (1-3). pp. 89-94. DOI 10.1016/j.cbi.2011.01.027.


Sang, Y., Xiong, G. and Maser, E. (2011) Identification of a new steroid degrading bacterial strain H5 from the Baltic Sea and isolation of two estradiol inducible genes J Steroid Biochem Mol Biol . DOI S0960-0760(11)00031-8 pii 10.1016/j.jsbmb.2011.01.018.


Seibert, H., Maser, E., Schweda, K., Seibert, S. and Gulden, M. (2011) Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cells Food and Chemical Toxicology, 49 (9). pp. 2398-2407. DOI 10.1016/j.fct.2011.06.055.


Skarydova, L., Skarka, A., Novotna, R., Zivna, L., Martin, H. J., Wsol, V. and Maser, E. (2009) Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin Toxicology, 264 (1-2). pp. 52-60.


Skarydova, L., Zivna, L., Xiong, G. M., Maser, E. and Wsol, V. (2009) AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids Chemico-Biological Interactions, 178 (1-3). pp. 138-144.


Staab, C. A., Hartmanova, T., El-Hawari, Y., Ebert, B., Kisiela, M., Wsol, V., Martin, H. J. and Maser, E. (2011) Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3 Chemico-Biological Interactions, 191 (1-3). pp. 95-103. DOI 10.1016/j.cbi.2011.01.016.


Staab, C. A., Stegk, J. P., Haenisch, S., Neiss, E., Kobsch, K., Ebert, B., Cascorbi, I. and Maser, E. (2011) Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method Chemico-Biological Interactions, 191 (1-3). pp. 104-112. DOI 10.1016/j.cbi.2010.12.027.


Stegk, J. P., Ebert, B., Martin, H. J. and Maser, E. (2009) Expression profiles of human 11 beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases Molecular and Cellular Endocrinology, 301 (1-2). pp. 104-108.

[img]

Verma, M., Martin, H. J., Haq, W., O'Connor, T. R., Maser, E. and Balendiran, G. K. (2008) Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers European Journal of Pharmacology, 584 (2-3). pp. 213-221. DOI 10.1016/j.ejphar.2008.01.036.


Xiong, G. M., Luo, Y. J., Jin, S. H. and Maser, E. (2009) Cis- and trans-regulatory elements of 3 alpha-hydroxysteroid dehydrogenase/carbonyl reductase as biosensor system for steroid determination in the environment Chemico-Biological Interactions, 178 (1-3). pp. 215-220.


Xiong, G., Draus, E., Luo, Y. J. and Maser, E. (2009) 3 alpha-Hydroxysteroid dehydrogenase/carbonyl reductase as a tool for isolation and characterization of a new marine steroid degrading bacterial strain Chemico-Biological Interactions, 178 (1-3). pp. 206-210.


Zeilinger, J., Steger-Hartmann, T., Maser, E., Goller, S., Vonk, R. and Lange, R. (2009) Effects of Synthetic Gestagens on Fish Reproduction Environmental Toxicology and Chemistry, 28 (12). pp. 2663-2670.


Zhang, T., Xiong, G. and Maser, E. (2011) Characterization of the steroid degrading bacterium S19-1 from the Baltic Sea at Kiel, Germany Chem Biol Interact, 191 (1-3). pp. 83-8. DOI S0009-2797(10)00685-X pii 10.1016/j.cbi.2010.12.021.

Article in a Scientific Journal - without review


Blum, A., Loerz, C., Martin, H. J., Staab-Weijnitz, C. A. and Maser, E. (2012) Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11 beta-hydroxysteroid dehydrogenase type 1 inhibitor Journal of Steroid Biochemistry and Molecular Biology, 128 (1-2). pp. 51-55.


Gong, W. J., Kisiela, M., Schilhabel, M. B., Xiong, G. M. and Maser, E. (2012) Genome Sequence of Comamonas testosteroni ATCC 11996, a Representative Strain Involved in Steroid Degradation Journal of Bacteriology, 194 (6). pp. 1633-1634.


Gong, W. J., Xiong, G. M. and Maser, E. (2012) Cloning, expression and characterization of a novel short-chain dehydrogenase/reductase (SDRx) in Comamonas testosteroni Journal of Steroid Biochemistry and Molecular Biology, 129 (1-2). pp. 15-21.


Gong, W. J., Xiong, G. M. and Maser, E. (2012) Oligomerization and negative autoregulation of the LysR-type transcriptional regulator HsdR from Comamonas testosteroni Journal of Steroid Biochemistry and Molecular Biology, 132 (3-5). pp. 203-211.


Hintzpeter, J., Stapelfeld, C., Loerz, C., Martin, H. J. and Maser, E. (2014) Green Tea and One of Its Constituents, Epigallocatechine-3-gallate, Are Potent Inhibitors of Human 11 beta-hydroxysteroid Dehydrogenase Type 1 PLoS ONE, 9 (1).


Kisiela, M., Skarka, A., Ebert, B. and Maser, E. (2012) Hydroxysteroid dehydrogenases (HSDs) in bacteria - A bioinformatic perspective Journal of Steroid Biochemistry and Molecular Biology, 129 (1-2). pp. 31-46.


Klauser, E., Guelden, M., Maser, E., Seibert, S. and Seibert, H. (2014) Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: Effects of genistein, quercetin and buthionine-sulfoximine Food and Chemical Toxicology, 67 . pp. 212-221.


Luo, D. X., Tong, D. J., Rajput, S., Wang, C., Liao, D. F., Cao, D. L. and Maser, E. (2012) Targeting Acetyl-CoA Carboxylases: Small Molecular Inhibitors and their Therapeutic Potential Recent Patents on Anti-Cancer Drug Discovery, 7 (2). pp. 168-184.


Malatkova, P., Ebert, B., Wsol, V. and Maser, E. (2012) Expression of human carbonyl reductase 3 (CBR3; SDR21C2) is inducible by pro-inflammatory stimuli Biochemical and Biophysical Research Communications, 420 (2). pp. 368-373.


Maser, E. and Rizner, T. L. (2012) Steroids and microorganisms Journal of Steroid Biochemistry and Molecular Biology, 129 (1-2). pp. 1-3.


Papavlassopoulos, H., Mishra, Y. K., Kaps, S., Paulowicz, I., Abdelaziz, R., Elbahri, M., Maser, E., Adelung, R. and Roehl, C. (2014) Toxicity of Functional Nano-Micro Zinc Oxide Tetrapods: Impact of Cell Culture Conditions, Cellular Age and Material Properties PLoS ONE, 9 (1).


Xiong, G., Draus, E. and Maser, E. (2008) Isolation and characterization of a steroid degrading bacterial strain Naunyn-Schmiedeberg's Archives of Pharmacology , 377, Suppl. 1 (Abstract No. 336). p. 68. DOI 10.1007/s00210-008-0275-x.

This list was generated on Fri Aug 18 03:22:05 2017 CEST.